KRYS R&D Expenses

Krystal Biotech Inc · R&D Expenses

KRYS logo

KRYS R&D Expenses

Latest reported$59.23M
KRYS TTM R&D Expenses ($3.21M → $59.23M)
High-resolution chart · PNG

KRYS r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Krystal Biotech Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
59,229,000
59,121,000
58,045,000
55,373,000
55,699,000
56,872,000
53,574,000
51,421,000
48,539,000
45,100,000
46,431,000
45,802,000
46,689,000
45,435,000
41,999,000
40,267,000
34,831,000
30,535,000
27,884,000
24,547,000
23,567,000
20,612,000
17,936,000
16,613,000
15,398,000
15,975,000
15,617,000
14,070,000
12,099,000
9,408,000
7,761,000
6,047,000
5,488,000
4,409,000
3,208,000
2,522,000
1,408,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.